Indo US Bio-Tech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 30.77 | 33.50 | 23.58 |
| Operating Expense | 25.30 | 28.80 | 18.02 |
| Net Profit | 4.70 | 3.68 | 5.05 |
| Net Profit Margin | 15.27 | 10.99 | 21.42 |
| Earning Per Share | 2.35 | 1.86 | 2.52 |
| EBIDTA | 5.42 | 4.80 | 5.59 |
| Effective Tax Rate | 1.28 | 6.38 | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 30.77 |
| Operating Expense | 25.30 |
| Net Profit | 4.70 |
| Net Profit Margin | 15.27 |
| Earning Per Share | 2.35 |
| EBIDTA | 5.42 |
| Effective Tax Rate | 1.28 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 103.84 | 72.84 | 61.74 |
| Operating Expenses Annual | 84.90 | 62.05 | 52.37 |
| Operating Profit Annual | 19.12 | 11.10 | 9.40 |
| Interest Annual | 1.49 | 1.51 | 1.18 |
| Depreciation | 1.10 | 0.80 | 0.83 |
| Net Profit Annual | 16.27 | 8.24 | 7.24 |
| Tax Annual | 0.26 | 0.55 | 0.15 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 103.84 |
| Operating Expenses Annual | 84.90 |
| Operating Profit Annual | 19.12 |
| Interest Annual | 1.49 |
| Depreciation | 1.10 |
| Net Profit Annual | 16.27 |
| Tax Annual | 0.26 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.10 | 0.19 | 0.05 |
| Cash Flow from Operations | 1.42 | 2.22 | 0.53 |
| Cash Flow from Investing | -0.79 | -2.53 | -6.67 |
| Cash Flow from Financing | -1.48 | 1.22 | 6.29 |
| Cash Flow at the End | 0.25 | 1.10 | 0.19 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1.10 |
| Cash Flow from Operations | 1.42 |
| Cash Flow from Investing | -0.79 |
| Cash Flow from Financing | -1.48 |
| Cash Flow at the End | 0.25 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 18.41 | 15.25 | 15.24 |
| PBIT Margin (%) | 17.35 | 14.15 | 13.90 |
| PBT Margin (%) | 5.71 | 4.84 | 2.30 |
| Net PROFIT Margin (%) | 15.67 | 11.31 | 11.73 |
| Return On Networth / Equity (%) | 23.03 | 14.06 | 15.51 |
| Return On Networth /Employed (%) | 21.13 | 14.30 | 14.37 |
| Return On Assets (%) | 19.12 | 11.43 | 12.08 |
| Total Debt / Equity (X) | 0.21 | 0.22 | 0.26 |
| Asset Turnover Ratio (%) | 1.22 | 1.01 | 1.03 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 18.41 |
| PBIT Margin (%) | 17.35 |
| PBT Margin (%) | 5.71 |
| Net PROFIT Margin (%) | 15.67 |
| Return On Networth / Equity (%) | 23.03 |
| Return On Networth /Employed (%) | 21.13 |
| Return On Assets (%) | 19.12 |
| Total Debt / Equity (X) | 0.21 |
| Asset Turnover Ratio (%) | 1.22 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 10.23 | 6.69 | 7.37 |
| Total Current Assets Annual | 86.73 | 73.09 | 59.91 |
| Non Current Assets Annual | 11.12 | 11.36 | 9.56 |
| Total Shareholders Funds Annual | 78.52 | 62.75 | 54.50 |
| Total Assets Annual | 97.84 | 84.46 | 69.47 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 10.23 |
| Total Current Assets Annual | 86.73 |
| Non Current Assets Annual | 11.12 |
| Total Shareholders Funds Annual | 78.52 |
| Total Assets Annual | 97.84 |
No Data Availabe
